baber/WOPTO huggingface dataset:
Patent CA-2744644-A1 (CA)
Inventor: ROSEN HERMANN
IPC: F16L41/06
Filed: 2009-11-24
Abstract: Disclosed is a maintenance device for an elongate, tubular hollow member (2) designed to conduct a fluid. Said maintenance device comprises a sealing mechanism (4) which is to seal a working zone (9) relative to surroundings (30) of the hollow member (2) and can be moved in one direction along the hollow member (2). A side of the sealing mechanism (4) that faces the hollow member (2) forms an at least partially curved surface and can be moved in the longitudinal direction of the hollow member (2), especially in order to be placed in the sealing position. A method for servicing an elongate, tubular hollow member (2) is also claimed.
Patent CA-2745248-A1 (CA)
Inventor: HOMAR MIHA
IPC: A61K9/20
Filed: 2009-11-30
Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a process for preparing dosage forms containing simvastatin and ezetimibe, comprising the steps of providing a first composition containing simvastatin, providing a second composition containing ezetimibe, and forming a dosage form comprising at least two separate compartments, wherein one compartment is formed using either the first or the second composition and another compartment is formed using the other composition. The present invention also relates to a process for preparing dosage forms containing simvastatin and ezetimibe, wherein the process involves a direct compression step. Furthermore, the present invention belongs to a dosage form obtained by this process, comprising at least two separate compartments, wherein one compartment contains simvastatin and one compartment contains ezetimibe. Finally, the present invention relates to a combination dosage form comprising a combination of simvastatin and ezetimibe present in two separate compartments of the dosage form.
Patent CA-2750499-A1 (CA)
Title: Novel synthetic agonists of tlr9
Inventor: KANDIMALLA EKAMBAR R
IPC: A61K39/00
Filed: 2010-01-28
Abstract: The invention relates to synthetic chemical compositions that are useful for modulation of Toll-Like Receptor (TLR)-mediated immune responses. In particular, the invention relates to agonists of Toll-Like Receptor 9 (TLR9) that generate unique cytokine and chemokine profiles.
Patent CA-2750965-A1 (CA)
Inventor: ROESE HEINRICH
IPC: B21C47/26
Filed: 2010-01-27
Abstract: An apparatus (1) for winding a strip (3), in particular a metal strip of varying thickness, into a coil (2) with a device for applying a deformable material onto the strip (3) that is to be wound, characterized in that the device comprises means (11, 22) for creating a resilient, in particular an elastic material or a self-expanding or foaming material for placement onto the coil (2).
Patent CA-2751407-A1 (CA)
Inventor: FRANZ WALTER
IPC: B01L3/00
Filed: 2010-02-03
Abstract: A test device for liquids of the human or animal body, comprises a tube-shaped housing, in which are disposed: an in-feed area for feeding in a prescribed quantity of a bodily fluid, a reaction area connected downstream of the in-feed area and separated from the same by at least one closed separating wall, and in which the bodily fluid is brought to a chemical reaction with at least one reagent, and an indication area connected downstream of the reaction area and separated from the same by a separating element having a defined through-hole, and in which an indication element is disposed, the bodily fluid being passed through the through-hole after reacting with the reagent. A cutting device is thereby provided by means of which the separating wall can be opened or destroyed.
Patent CA-2751577-A1 (CA)
Inventor: SABIO SERGE
IPC: C04B22/08
Filed: 2010-02-16
Abstract: La présente invention concerne un liant hydraulique rapide comprenant du ciment, au moins un premier superplastifiant, un sel de calcium et au moins un second superplastifiant. Le second superplastifiant est différent du premier superplastifiant et comprend une chaîne principale et des groupes pendants reliés à la chaîne principale adaptés à se séparer de la chaîne principale en milieu basique, d'où il résulte que le second superplastifiant a une action fluidifiante qui croît au moins temporairement dans le temps en milieu basique.
Patent CA-2752866-A1 (CA)
Inventor: BERKHAHN SVEN-OLAF
IPC: B60L50/16
Filed: 2010-02-16
Abstract: An apparatus and a method for transferring data and energy over network units of a defined network. The apparatus has at least two units, a bus coupling the units with a receive line and a transmit line and a bus control device coupled with the bus, the bus control device having first means for controlling the transfer of data defined by the defined network as data voltage signals over the transmit line and over the receive line, second means for charging the data voltage signals on the transmit line with first supply voltage signals adapted for voltage supply of units of a first plane system, and third means for charging the data voltage signals on the receive line with second supply voltage signals adapted for voltage supply of units of a second plane system.
Patent CA-2754284-A1 (CA)
Title: Fluid level control mechanism
Inventor: FILIPPI WILLIAM K
IPC: E21B47/047
Filed: 2011-10-03
Abstract: A fluid level control mechanism comprising a float assembly, a flow line assembly, an upper centralizer, and a lower centralizer. The float assembly has a cylindrical outer float tube and a cylindrical inner float tube connected by upper and lower end plates to form a sealed cavity. The flow line assembly has a main flow line capable of passing a fluid, a diverter flow line, and a diverter valve. The diverter valve is connected to the lower end plate of the float assembly via a lever arm, such that the float assembly is capable of sliding along the length of the main flow line in response to a fluid level. Downward movement of the float assembly opens the diverter valve and upward movement of the float assembly closes the diverter valve.  The upper and lower centralizers center the mechanism within a well bore.
Patent CA-2754345-A1 (CA)
Inventor: BALAKIN VLADIMIR EGOROVICH
IPC: G21G4/00
Filed: 2009-03-04
Abstract: The invention relates generally to treatment of solid cancers.  More particularly, the invention relates to a multi-field charged particle cancer therapy method and apparatus coordinated with negative ion beam creation, ion beam focusing, charged particle acceleration, patient rotation, and/or patient respiration. Preferably, the charged particle therapy is performed on a patient in a partially immobilized and repositionable position. Proton delivery is preferably timed to patient respiration via control of charged particle beam injection, acceleration, and/or targeting methods and apparatus.
Patent CA-2754438-A1 (CA)
Inventor: CORNWALL MARK K
IPC: G08C17/02
Filed: 2011-10-07
Abstract: Radio messages delivering utility consumption data may be transmitted by endpoints. Each endpoint may contain a meter, such as an electric, natural gas and/or water meter. A portable unit (such as, for example, a handheld meter reading unit) may traverse a route among the endpoints and obtain the consumption data. Endpoints may send messages, periodically and/or in response to a command. Such messages may provide flags or other data indicating a condition of the endpoint. The flags or other data may be interpreted by computer code or logic within the portable unit to determine the condition of the endpoint, if a conditional command is indicated, and if so, which conditional command.  Having selected an appropriate conditional or "reflex" command, the portable unit may transmit the conditional command to the endpoint and record data contained in a reply.
Patent CA-2754742-A1 (CA)
Inventor: HEDGES BRADLEY R
IPC: A01H5/10
Filed: 2011-03-22
Abstract: According to the invention, there is provided a novel soybean variety designated XB09P11. This invention thus relates to the seeds of soybean variety XB09P11, to the plants of soybean XB09P11 to plant parts of soybean variety XB09P11 and to methods for producing a soybean plant produced by crossing plants of the soybean variety XB09P11 with another soybean plant, using XB09P11 as either the male or the female parent.
Patent CA-2759344-A1 (CA)
Title: Antimicrobial surface treatment composition comprising a peroxygen compound, a chlorinated isocyanurate salt, and a bleach activator
Inventor: STEVENSON RANDAL D
IPC: A01N59/00
Filed: 2011-11-22
Abstract: A surface treatment powder comprising (a) about 50 wt.% or more of a percarbonate, perphosphate, persulfate, peroxide or perborate salt; (b) about 0.2 - 10 wt.%  of a chlorinated isocyanurate salt; and (c) a bleach activator, and method of using same to inhibit the growth of a microorganism on a surface.
Patent CA-2761332-A1 (CA)
Title: Dispositif pyrotechnique a mise a feu securisee
Inventor: BODO LIONEL
IPC: A01M21/04
Filed: 2011-12-08
Abstract: Dispositif pyrotechnique (1) destiné à la destruction des animaux creusant des galeries tels qu'une taupe par la mise à feu d'une charge pyrotechnique (2), comportant des moyens de détection (3) de l'animal et un circuit électrique de mise à feu (4) comprenant un contacteur de mise à feu (5) piloté par les moyens de détection (3). Le dispositif pyrotechnique (1) comporte : - un premier boîtier (6) destiné à être installé au sol (28), connecté électriquement à la charge pyrotechnique (2), et comportant les moyens de détection (3), - un deuxième boîtier (7) destiné à être installé au sol à distance du premier boîtier (6) auquel il est relié par l'intermédiaire de moyens de connexion (8) filaires, et comportant des premiers moyens d'interruption (9) du circuit électrique de mise à feu (4) permettant sélectivement d'interrompre ou d'établir la continuité d'un premier tronçon (10) de circuit électrique de mise à feu (4).
Patent CA-2763089-A1 (CA)
Title: System and method for management of scalability information in scalable video and audio coding systems using control messages
Inventor: ELEFTHERIADIS ALEXANDROS
IPC: H04N19/187
Filed: 2007-03-27
Abstract: Systems and methods are provided for communicating timely information related to the scalability layer structure of signals received by decoders and other components in a video and/or audio communication system. For a communication system, which uses the Standard H.264 SVC coding format, standard SSEI messages are modified or supplemented to include the ability to signal scalability layer structure information and changes thereof.  Recipients can use the signal scalability layer information to properly process or decode received signals.
Patent CA-2763727-A1 (CA)
Title: Improvement of immunodetectability
Inventor: UHLEN MATHIAS
IPC: G01N33/537
Filed: 2009-06-26
Abstract: In the present disclosure, there is provided a method for improving the immunodetectability of at least one protein in an optionally diluted sample of blood, serum or plasma, comprising a step of heating the sample to a temperature of 64 - 85 °C  prior to a contact between the sample and at least one affinity ligand for detection and/or quantification of the at least one protein.
Patent CA-2764005-A1 (CA)
Title: A compact ultra wide band antenna for transmission and reception of radio waves
Inventor: CLOW NATHAN
IPC: H01Q9/36
Filed: 2010-06-08
Abstract: A stacked disk loaded antenna (80) that uses a dual double tuned impedance matching networks to broadband match the radiation resistance to a 50 .OMEGA. port. Using two antenna elements (31, 64 ) in a stacked construction results in the antenna effectively combining the bandwidth ranges of both the antenna elements and removes the requirement for external tuning, which will add weight to an antenna structure. The stacked antenna system can be employed within communication systems operating within the HF and UHF bands.
Patent CA-2767066-A1 (CA)
Title: Pyridine and pyrazine derivatives as protein kinase modulators
Inventor: BARSANTI PAUL A
IPC: C07D401/12
Filed: 2010-07-28
Abstract: The present invention provides a compound of formula (I), and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a diseease or condition mediated by CDK9.
Patent CA-2770231-A1 (CA)
Inventor: HAJEK MICHAELA
IPC: B01D15/00
Filed: 2010-08-09
Abstract: The present invention relates to a device for cleaning blood, blood substitutes, or solutions for introduction into the human and/or animal blood circuit and for exchanging gases in blood, blood substitutes, or solutions for introduction into the human and/or animal blood circuit, comprising at least one gas-permeable membrane and a carrier, which is coated with substances for adsorptively removing toxins of biological and synthetic chemical origin and metabolites and decomposition products thereof present in blood, blood substitutes, or solutions for introduction into the human and/or animal blood circuit, a use of the stated device and a method for gently and simultaneously removing toxins of biological and synthetic chemical origin and metabolites and decomposition products thereof from blood, blood substitutes, or solutions for introduction into the human and/or animal blood circuit and for enriching the blood, blood substitutes, or solutions for introduction into the human and/or animal blood circuit with oxygen.
Patent CA-2774040-A1 (CA)
Title: 2, 3-dihydro-1h-inden-2-yl urea derivatives and medical uses thereof
Inventor: KANEKO HIROAKI
IPC: A61P17/00
Filed: 2010-09-30
Abstract: In order to provide a low molecular weight compound that has p38MAPK inhibitory activity and the accompanying TNFa production suppression activity and that has a favorable pharmacokinetic profile as a pharmaceutical and decreased hepatotoxicity, and to provide a pharmaceutical application of same, disclosed is a 2,3-dihydro-1H-indene-2-ylurea derivative represented below, a pharmacologically acceptable salt thereof, and a therapeutic agent or preventative agent that contains same as an active ingredient and that is for allergic dermatitis, inflammatory bowel disease, and pain.
Patent CA-2774295-A1 (CA)
Inventor: SUZUKI TAKASHI
IPC: H04L47/36
Filed: 2007-09-14
Abstract: Une méthode de transmission de paquet de données lors d'une panne de transmission HARQ (Hybrid Automatic Repeat Request) comprend les étapes de vérifier si des changements aux caractéristiques de rendement sur erreur de la transmission HARQ sont supérieurs à un seuil et/ou une indication de détérioration des conditions de canal ou inférieurs au seuil; si oui, resegmenter des données RLC-SDU ou RLC-PDU en paquets de données PDU plus petits et transmettre lesdites données RLC-PDU resegmentées et, si non, transmettre les données RLC-PDU précédentes.
Patent CA-2774842-A1 (CA)
Title: Hexagonal boron nitride powder and method for producing same
Inventor: GOHARA TAISEI
IPC: C01B21/064
Filed: 2010-10-08
Abstract: Disclosed is an h-BN powder wherein, in a BN powder, the ratio of the major axis diameter and thickness of primary particles is controlled to 5-10, the aggregate size of the primary particles expressed in the average particle diameter (D50) is controlled to 2-200 µm inclusive, and the bulk density is controlled to 0.5-1.0 g/cm3 so as to give a low porosity in aggregates of the primary particles and improve the binding force among the particles, thereby achieving good filling properties and, in its turn, a high heat conductivity.
Patent CA-2776430-A1 (CA)
Inventor: FORSELL PETER
IPC: A61F2/26
Filed: 2009-10-09
Abstract: A penis erection stimulation system, comprises an infusion device adapted for implantation inside the patient's body and at least one reservoir adapted for implantation inside the patient's body in fluid connection with the infusion device to supply to the infusion device a substance to be injected into the patient's body. The implantable system may comprise a mixing chamber for mixing a first substance from at least one first compartment with a second substance from one or more second compartment, wherein the implantable system comprises at least one pump adapted for implantation inside the patient's body to advance the first substance from the at least one first compartment through the mixing chamber to the infusion device, and wherein the one or more second compartments are movable into a position within the mixing chamber such that the second substance of the one or more second compartments mixes with the first substance when the first substance is advanced through the mixing chamber.
Patent CA-2777806-A1 (CA)
Inventor: OZIN GEOFFREY A
IPC: G01N21/00
Filed: 2010-10-06
Abstract: The present disclosure provides methods, systems and devices for a photonic crystal combinatorial sensor. The photonic crystal sensor may include an array of photonic crystal materials, wherein each photonic crystal material has a reflected wavelength in a respective initial wavelength range. At least one a first one of the photonic crystal materials may be configured to have a response to an external stimulus different from at least a second one of the photonic crystal materials, the different response resulting in a change in the reflected wavelength of the first photonic crystal material that is an optically detectable difference from the second photonic crystal material. The optically detectable difference may provide an optically detectable response pattern of reflected wavelengths in the array. The sensor may be reversible and reusable.
Patent CA-2778105-A1 (CA)
Inventor: HOLT MARK DOMINIS
IPC: B65D41/36
Filed: 2010-10-22
Abstract: A vial adapter includes a base having first and second opposing sides, a spike depending from the first side of the base, the spike having a spike passageway, and a connector disposed on the second side of the base, the connector having a connector passageway that is in fluid communication with the spike passageway. The vial adapter may be combined with a vial.
Patent CA-2778997-A1 (CA)
Title: Methods and systems for radio frequency neurotomy
Inventor: WRIGHT ROBERT E
IPC: A61B18/14
Filed: 2010-11-05
Abstract: Methods and systems for spinal radio frequency neurotomy. Systems include needles capable of applying RF energy to target volumes within a patient. Such target volumes may contain target medial branch nerves along vertebrae or rami proximate the sacrum. Such procedures may be used to ablate or cauterize a portion of the targeted nerve, thus blocking the ability of the nerve to transmit signals to the central nervous system. Disclosed needles may be operable to asymmetrically, relative to a central longitudinal axis of the needle, apply RF energy. Such asymmetry facilitates procedures where a tip of the needle is placed proximate to anatomical structures for location verification. Then RF energy may be applied in a selectable direction relative to the needle tip to ablate volumes that include the targeted medial branch nerves or rami, thus denervating facet joints or the sacroiliac joint, respectively, to relieve pain in a patient.
Patent CA-2779044-A1 (CA)
Inventor: CALLISTER JEFFREY P
IPC: A61B1/303
Filed: 2005-04-27
Abstract: The invention is directed to an endoscopic assembly having an endoscope, particularly a flexible hysteroscope and an outer sheath disposed about a length of the shaft of the hysteroscope which has an expandable member such as an inflatable balloon for sealing the assembly within a body lumen or cavity. Specifically, the endoscope assembly is configured for delivery of an occlusive contraceptive member to the patient's fallopian tube.  The invention is also directed to an endoscope having a driving member for movement of a medical device within the working lumen of an endoscope. In one embodiment the driving member is a friction wheel which engages an elongated medical device disposed within the working channel of the endoscope to effect longitudinal movement of the medical device.
Patent CA-2779675-A1 (CA)
Inventor: VARNAS SAULIUS RAYMOND
IPC: G02C7/06
Filed: 2010-11-09
Abstract: A progressive ophthalmic lens element (100) is disclosed. The progressive ophthalmic lens element (100) includes an upper viewing zone (102), a lower viewing zone (104), a corridor (106), and a peripheral region (108) disposed on each side of the lower viewing zone (104). The upper viewing zone includes a distance reference point (DRP) and a fitting cross (1 10), and provides a first refractive power for distance vision. The lower viewing zone (104), which is for near vision, provides an addition power relative to the first refractive power. The corridor (106) connects the upper (102) and lower zones (104) and provides a refractive power varying from that of the upper viewing zone (102) to that of the lower viewing zone (104). Each peripheral region (108) includes a zone (120, 122) of positive power relative to the addition power which provides therein a positive refractive power relative to the refractive power of the lower viewing zone (104). The zones (120, 122) of relative positive power are disposed immediately adjacent to the lower viewing zone (104) such that the lower viewing zone interposes (104) the zones of relative positive power (120, 122).
Patent CA-2783060-A1 (CA)
Inventor: ABE KAZUHIRO
IPC: A61M25/02
Filed: 2012-07-13
Abstract: The present invention relates to a fixing device (11) for fixing a tubular catheter (1) which is equipped with a plate-shaped fixing device body (21) and a fixed member (41). The plate-shaped fixing device body (21) possesses retaining parts (22) and a pair of wing pieces (23) that form a catheter retention slot (25). The fixed member (41) can be fitted onto the fixing device body (21) by being slid along the planar direction of the fixing device body (21). When the fixed member (41) is fitted, the retaining parts (22) are compressed by the fixed member (41), thus narrowing the catheter retention slot (25).
Patent CA-2783381-A1 (CA)
Inventor: MILOSEVIC BORKA
IPC: H02J13/00
Filed: 2012-07-19
Abstract: Devices and methods for the decentralized, coordinated control of the power factor on an electrical distribution system are provided. A first controller provides control over a first segment supplied by a first substation and a second controller provides control over a second segment supplied by a second substation. A first controller may include a network interface and data processing circuitry. The network interface may receive first measurements associated with the first segment of an electrical distribution system and transmit a control signal configured to control equipment of the first segment of the electrical distribution system. The first controller is configured not to control equipment of the second segment. This decentralized coordinated control improves the power factor over conventional, local control schemes.
Patent CA-2785020-A1 (CA)
Inventor: EHRICH MATHIAS
IPC: G16B25/20
Filed: 2010-12-20
Abstract: Provided are methods for identifying the presence or absence of a chromosome abnormality by which a cell-free sample nucleic acid from a subject is analyzed. In certain embodiments, provided are methods for identifying the presence or absence of a fetal chromosome abnormality in a nucleic acid from cell-free maternal blood.